In addition, blocking IL-6 or IL-6R in prostate cancer and methylcholanthrene-induced skin squamous cell carcinoma mouse models resulted in the prominent reduction of MDSCs infiltrating tumors and in the suppression of tumor development [58,61]. This evidence concerns the gene IL6 and neoplasm.